Original Research

Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials

Xiao B, Wang W, Zhang D

OncoTargets and Therapy 2018, 11:5059-5074

Published Date: 21 August 2018